General Information of Drug (ID: DM3L2GT)

Drug Name
O6-Benzylguanine alkylade Drug Info
Synonyms KRX-0402; O6-Benzylguanine (BG)
Indication
Disease Entry ICD 11 Status REF
Sarcoma 2A60-2C35 Phase 3 [1]
Cross-matching ID
TTD Drug ID
DM3L2GT

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
6-Benzyloxy-9H-purin-2-ylamine DMFI7A8 Discovery agent N.A. Investigative [2]
S-Methylcysteine DMAMRKS Discovery agent N.A. Investigative [3]
6-Benzyloxy-5-nitroso-pyrimidine-2,4-diamine DMUFSE2 Discovery agent N.A. Investigative [2]
6-Benzyloxy-5-nitro-pyrimidine-2,4-diamine DMK8XIO Discovery agent N.A. Investigative [2]
Benzylcysteine DMTCYHM Discovery agent N.A. Investigative [3]
6-Allyloxy-9H-purin-2-ylamine DMI2XUQ Discovery agent N.A. Investigative [4]
⏷ Show the Full List of 6 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
O-6-methylguanine-DNA-alkyltransferase (MGMT) TTJ8DV7 MGMT_HUMAN Modulator [1]

References

1 Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. J Clin Oncol. 2009 Mar 10;27(8):1262-7.
2 Inhibition of human O6-alkylguanine-DNA alkyltransferase and potentiation of the cytotoxicity of chloroethylnitrosourea by 4(6)-(benzyloxy)-2,6(4)-... J Med Chem. 1998 Feb 12;41(4):503-8.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
4 Resistance-modifying agents. 8. Inhibition of O(6)-alkylguanine-DNA alkyltransferase by O(6)-alkenyl-, O(6)-cycloalkenyl-, and O(6)-(2-oxoalkyl)gua... J Med Chem. 2000 Nov 2;43(22):4071-83.